# ANTHEM-HFrEF Pivotal Study

> **NCT03425422** · NA · TERMINATED · sponsor: **LivaNova** · enrollment: 533 (actual)

## Conditions studied

- Heart Failure
- Heart Failure, Congestive
- Heart Failure, Systolic

## Interventions

- **DEVICE:** VITARIA System

## Key facts

- **NCT ID:** NCT03425422
- **Lead sponsor:** LivaNova
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-01
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 533 (ACTUAL)
- **Why stopped:** Company decision to stop enrolling not associated with any safety concerns.
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03425422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03425422, "ANTHEM-HFrEF Pivotal Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03425422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*